Cargando…

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

The literature reports low rates of breast conservation after neoadjuvant chemotherapy for operable breast cancers not amenable to initial breast-conserving surgery. This study aims to compare the outcome of lobular vs ductal carcinomas after neoadjuvant chemotherapy. Between 1989 and 1999, 750 pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollet, M A, Savignoni, A, Pierga, J-Y, Lae, M, Fourchotte, V, Kirova, Y M, Dendale, R, Campana, F, Sigal-Zafrani, B, Salmon, R, Fourquet, A, Vincent-Salomon, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259192/ https://www.ncbi.nlm.nih.gov/pubmed/18253121 http://dx.doi.org/10.1038/sj.bjc.6604229

Ejemplares similares

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?
por: Sigal-Zafrani, B, et al.
Publicado: (2007)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy
por: Fournier-Bidoz, N., et al.
Publicado: (2009)

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment
por: Bollet, Marc A, et al.
Publicado: (2009)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Second malignancies after breast cancer: the impact of different treatment modalities
por: Kirova, Y M, et al.
Publicado: (2008)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement
por: Hajage, David, et al.
Publicado: (2011)

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool
por: Chira, Ciprian, et al.
Publicado: (2013)

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
por: Daveau, C, et al.
Publicado: (2014)

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors
por: Pérez-Mies, Belén, et al.
Publicado: (2022)

Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience
por: Baude, Jérémy, et al.
Publicado: (2023)

Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial
por: Jornet, Diane, et al.
Publicado: (2021)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
por: Vincent-Salomon, A, et al.
Publicado: (2007)

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
por: Vincent-Salomon, Anne, et al.
Publicado: (2007)

Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

Risk factors for ductal and lobular breast cancer: results from the nurses' health study
por: Kotsopoulos, Joanne, et al.
Publicado: (2010)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases
por: Cutuli, Bruno, et al.
Publicado: (2015)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

1586P Assessment of side effects of radiation therapy in patients with COVID-19 treated for early-stage breast cancer
por: Allali, S., et al.
Publicado: (2021)

Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer
por: Allali, S., et al.
Publicado: (2021)

Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study
por: Allali, S., et al.
Publicado: (2022)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study
por: Nicaise, Benjamin, et al.
Publicado: (2021)

Phylogenetic analysis of combined lobular and ductal carcinoma of the breast
por: Kobayashi, Hiroko, et al.
Publicado: (2021)

Radiothérapie mammaire dans le contexte de la pandémie de COVID-19 : astuces pratiques en période épidémique et conseils pour la reprise de l’activité en fin de crise
por: Loap, P., et al.
Publicado: (2020)

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience
por: Cutuli, B, et al.
Publicado: (2009)

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
por: Hoosein, MM, et al.
Publicado: (2013)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

Collective invasion in ductal and lobular breast cancer associates with distant metastasis
por: Khalil, Antoine A., et al.
Publicado: (2017)

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
por: Choesmel, Valérie, et al.
Publicado: (2004)

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery
por: Gosset, Marie, et al.
Publicado: (2016)

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?
por: Costarelli, Leopoldo, et al.
Publicado: (2017)

Histopathological and clonal study of combined lobular and ductal carcinoma of the breast
por: Tazaki, Eri, et al.
Publicado: (2013)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
por: Delpech, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3rhvcl846n91q67dsagvl4cp33